Evidence map›Paper›PMID 42113543›Full record

ArticleJAMA neurology2026

Genetic Testing by Age at Onset in Parkinson Disease.

Alexander Balck, Eva-Juliane Vollstedt, Ana Westenberger, Lara M Lange, Joanne Trinh, Meike Kasten, Katja Lohmann, Norbert Brüggemann, Claudia Trenkwalder, Brit Mollenhauer and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Does genetic testing remain relevant in advanced Parkinson's disease?Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  3. Genomic Landscape of Early-Onset and Familial Latin American Parkinson's Patients.medRxiv : the preprint server for health sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alexander BalckInstitute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Eva-Juliane VollstedtInstitute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Ana WestenbergerInstitute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Lara M LangeInstitute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Joanne TrinhInstitute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Meike KastenUniversity of Lübeck, Lübeck, Germany.
Katja LohmannInstitute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Norbert BrüggemannInstitute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Claudia TrenkwalderParacelsus-Elena-Klinik, Kassel, Germany.
Brit MollenhauerParacelsus-Elena-Klinik, Kassel, Germany.
Roy AlcalayGray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Kamalini Ghosh GalvelisParkinson's Foundation, New York, New York.
James C BeckParkinson's Foundation, New York, New York.
Peter BauerCENTOGENE, Rostock, Germany.
Christine KleinInstitute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Inke R KönigInstitut für Medizinische Biometrie und Statistik, University of Lübeck, Lübeck, Germany.
Global Parkinson’s Genetics Program (GP2), the ROPAD Study Group, and the PDGENEration Study

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42113543
PMCPMC13162140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.